Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse - Moderna (NASDAQ:MRNA)

Summary by Benzinga
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Pfizer Inc. (NYSE:PFE) and recommended buying more of the stock. On Sept. 16, Cantor Fitzgerald analyst Louise Chen reiterated Pfizer with an Overweight rating and maintained a $45 price target. “Six Flags (NYSE:FUN), I don't know, it feels like it's two flags,” Cramer said. “This has just been a merger from hell. I'm not really into the stock.” On Sept. 16, JPMorgan analyst Matthew…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Jim Cramer

Jim Cramer

New York State

New York State

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal